A Genomic Signature [JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2] Predicts Baseline Resistance to Nivolumab in Advanced NSCLC.

被引：0
|
作者：
Pilotto, S. [1 ]
Grizzi, G. [1 ]
Sperduti, I. [2 ]
Simbolo, M. [3 ]
Vicentini, C. [3 ]
Calio, A. [3 ]
Caccese, M. [1 ]
Mafficini, A. [3 ]
Carbognin, L. [1 ]
Corbo, V. [3 ]
Gkountakos, A. [3 ]
Santo, A. [1 ]
Infante, M. [4 ]
Brunelli, M. [3 ]
Scarpa, A. [3 ]
Tortora, G. [1 ]
Bria, E. [5 ]
机构：
[1] Univ Verona, Aoui, Med Oncol, Verona, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
[3] Univ & Hosp Trust Verona, Sect Anat Pathol, Dept Diagnost & Publ Hlth, Verona, Italy
[4] Osped Borgo Trento, Univ & Hosp Trust, Verona, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Div Med Oncol, Rome, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Genomic signature; advanced NSCLC; Immunotherapy resistance;
D O I：
10.1016/j.jtho.2018.08.1236
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-12
引用
收藏
页码：S734 / S735
页数：2
相关论文
共 50 条
  • [11] JAK2/STAT3 is associated with the inflammatory process in periapical granuloma
    Zhang, Chen
    Liu, Jun
    Yuan, Changqing
    Ji, Qiuxia
    Chen, Daiyun
    Zhao, Han
    Jiang, Weijie
    Ma, Kangjie
    Liu, Lingshuang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (01): : 190 - 197
  • [12] Targeting the JAK2/STAT3 signaling pathway for chronic pain
    Dai, Xin-Yi
    Liu, Lin
    Song, Fan-He
    Gao, Shao-Jie
    Wu, Jia-Yi
    Li, Dan-Yang
    Zhang, Long-Qing
    Liu, Dai-Qiang
    Zhou, Ya-Qun
    Mei, Wei
    AGING AND DISEASE, 2024, 15 (01): : 186 - 200
  • [13] Role of the JAK2/STAT3 pathway on infection of Francisella novicida
    Matsumoto, Sonoko
    Shimizu, Takashi
    Uda, Akihiko
    Watanabe, Kenta
    Watarai, Masahisa
    PLOS ONE, 2024, 19 (09):
  • [14] LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
    Shaobo Yu
    Xin Gao
    Sidi Liu
    Xiangjun Sha
    Siyuan Zhang
    Xinmiao Zhang
    Dongsheng Sun
    Xingming Jiang
    Cancer Gene Therapy, 2024, 31 : 552 - 561
  • [15] Schisandrin inhibits VSMCs proliferation and migration by arresting cell cycle and targeting JAK2 to regulating the JAK2/STAT3 pathway
    Huang, Qiuxia
    Liu, Xinyao
    Yu, Jinjin
    Liu, Yang
    Song, Huixin
    Zhang, Xinya
    Zhou, Lili
    Wang, Siqi
    Niu, Xiaofeng
    Li, Weifeng
    TISSUE & CELL, 2024, 89
  • [16] LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
    Yu, Shaobo
    Gao, Xin
    Liu, Sidi
    Sha, Xiangjun
    Zhang, Siyuan
    Zhang, Xinmiao
    Sun, Dongsheng
    Jiang, Xingming
    CANCER GENE THERAPY, 2024, 31 (04) : 552 - 561
  • [17] Small molecule inhibitor azd1480 reverses radiotherapy resistance in NSCLC by targeting JAK2/STAT3 pathway
    Mao, Ying
    Yao, Yang
    Liu, Li
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 45 - 50
  • [18] The JAK/STAT pathway is essential for opioid-induced cardioprotection:: JAK2 as a mediator of STAT3, Akt, and GSK-3β
    Gross, Eric R.
    Hsu, Anna K.
    Gross, Garrett J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (02): : H827 - H834
  • [19] Activation of dendritic cells via inhibition of Jak2/STAT3 signaling
    Nefedova, Y
    Cheng, PY
    Gilkes, D
    Blaskovich, M
    Beg, AA
    Sebti, SM
    Gabrilovich, DI
    JOURNAL OF IMMUNOLOGY, 2005, 175 (07): : 4338 - 4346
  • [20] Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation
    Ahr, Barbara
    Denizot, Mélanie
    Robert-Hebmann, Véronique
    Brelot, Anne
    Biard-Piechaczyk, Martine
    J. Biol. Chem., 1600, 8 (6692-6700):
12345